Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Functional Magnetic Resonance Imaging in Patients With Obstructive Sleep Apnea Syndrome

Functional Magnetic Resonance Imaging in Patients With Obstructive Sleep Apnea Syndrome, With and Without CPAP, During Wakefulness - Impact on Cognitive Functions

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The obstructive sleep apnea syndrome (OSAS) involves recurrent sleep-related upper airways (UA) collapse. UA mechanical properties and neural control are altered, imposing a mechanical load on inspiration. UA collapse does not occur during wakefulness, hence arousal-dependent compensation. Experimental inspiratory loading in normal subjects elicits respiratory-related cortical activity during wakefulness. The objective of this study is to test whether awake OSAS patients would exhibit a similar cortical activity. Whether or not such cortical compensatory mechanisms have cognitive consequences would be also analyze.

Who May Be Eligible (Plain English)

Inclusion criteria : 1. OSAS patients - severe OSAS with an Apnea-Hypopnea Index (AHI) \> 30/h - without CPAP treatment 2. Non-OSAS patients - absence of OSAS (AHI \< 15/h and absence of excessive daytime sleepiness with Epworth score \<11) Non-inclusion criteria : - \< 18 years old - \>75 years old - left-handed - BMI\> 40 kg/m² - another sleep disorder - central component of sleep apnea syndrome (central apnea index\> 5 / h) - current or past neurological pathology - respiratory pathology (obstructive ventilatory disorder, restrictive ventilatory disorder, hypercapnia) - MRI contraindication (metallic foreign body, claustrophobia, pregnant woman, etc.) - taking drugs that can modify the BOLD signal on MRI (psychotropic drugs, vasodilators, vasoconstrictors, etc.), - uncorrected sensory impairment (vision or hearing) - protected by law. Exclusion criteria : - pregnant woman according to the positive beta-hCG test result - left-handed following the laterality questionnaire - MINI results showing: - a current mood episode - a current disorder of the use of psychoactive substances or in the last 6 months (excluding tobacco) - an eating disorder - a diagnosis of bipolar disorder, current or past schizophrenia Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion criteria : 1. OSAS patients * severe OSAS with an Apnea-Hypopnea Index (AHI) \> 30/h * without CPAP treatment 2. Non-OSAS patients * absence of OSAS (AHI \< 15/h and absence of excessive daytime sleepiness with Epworth score \<11) Non-inclusion criteria : * \< 18 years old * \>75 years old * left-handed * BMI\> 40 kg/m² * another sleep disorder * central component of sleep apnea syndrome (central apnea index\> 5 / h) * current or past neurological pathology * respiratory pathology (obstructive ventilatory disorder, restrictive ventilatory disorder, hypercapnia) * MRI contraindication (metallic foreign body, claustrophobia, pregnant woman, etc.) * taking drugs that can modify the BOLD signal on MRI (psychotropic drugs, vasodilators, vasoconstrictors, etc.), * uncorrected sensory impairment (vision or hearing) * protected by law. Exclusion criteria : * pregnant woman according to the positive beta-hCG test result * left-handed following the laterality questionnaire * MINI results showing: * a current mood episode * a current disorder of the use of psychoactive substances or in the last 6 months (excluding tobacco) * an eating disorder * a diagnosis of bipolar disorder, current or past schizophrenia

Treatments Being Tested

DIAGNOSTIC_TEST

functional magnetic resonance imaging

functional magnetic resonance imaging

Locations (1)

Chu Reims
Reims, France